Abalone Bio

We create activating antibodies to treat diseases others can’t.

Y CombinatorWinter 2020ActiveHealthcareDrug Discovery and DeliveryMachine LearningSynthetic BiologyTherapeuticsDrug discovery

What they do

Problem

We create activating antibodies to treat diseases others can’t.

Founders

Richard Yu

Founder

Rich has been in or around biotech startups since 2008, when co-founded GPB, an algae biofuel startup. He was also Scientific and Operations Director at MBC Biolabs, the leading biotech incubator in SF, and Principal at Mission Bay Capital, a life science VC fund. Prior, he was an investigator at The Molecular Sciences Institute studying how cells process information. PhD (2000) Molecular Biophysics and Biochemistry, Yale BA (1993) Biophysics and Computer Science (AI and Graphics), UC Berkeley